ASCO 2021 Highlights on the Outcomes in Patients ≥ 65 Years in the ASCENT Study of Sacituzumab Govitecan in mTNBC

UCLA Health

https://www.uclahealth.org/

At UCLA Health, we provide the best health care, using the latest medical technology — healing humankind one patient at a time.

ASCO 2021 Highlights on the Outcomes in Patients ≥ 65 Years in the ASCENT Study of Sacituzumab Govitecan in mTNBC

By UCLA Health FEATURING Sara A. Hurvitz

97 views

October 13, 2021

Comments 1

IGCS 2024 Summary and Highlights: Key Trial Insights on Endometrial …

UCLA Health

D. Chase

54 views

Efficacy and Toxicity of 177Lu-PSMA-617 for mCRPC: Results From the …

UCLA Health

V. Murthy

45 views

Different Uses of Efanesoctocog Alfa in Hemophilia A: Prophylaxis, P…

UCLA Health

D. Quon

50 views

ESMO 2024 Insights: VOLGA Trial - ctDNA Clearance in Cisplatin-Ineli…

2024 ESMO Annual Meeting Insights Hub

A. Drakaki

54 views

Best of ASCO® Los Angeles 2024: DIPPER Trial - Adjuvant PD-1 Blockad…

UCLA Health

D. Wong

48 views

Best of ASCO® Los Angeles 2024: The PATHWay Trial - Adjuvant Pembro …

UCLA Health

D. Wong

124 views

Best of ASCO® Los Angeles 2024: E3311 ECOG-ACRIN Trial - Transoral S…

UCLA Health

D. Wong

38 views

ASCO® 2024 Insights: "TROPION-Lung05 Study - Intracranial Efficacy o…

2024 ASCO® Annual Meeting Insights Hub

A. Lisberg

193 views

ASCO® 2024 Insights: "LIBRETTO-432 Trial - Adjuvant Selpercatinib vs…

2024 ASCO® Annual Meeting Insights Hub

J. Goldman

160 views

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

UCLA Health

G. Konecny

326 views

ASCO® 2024 Insights: "Randomized ARC-9 Study to Evaluate Etrumadenan…

2024 ASCO® Annual Meeting Insights Hub

Z. Wainberg

69 views

AACR 2024 Insights: "IMvoke010 - Comparing Atezolizumab to Placebo A…

UCLA Health

D. Wong

152 views

HERTHENA-Lung01 Study: Patritumab Deruxtecan as a HER3 Target in EGF…

UCLA Health

A. Lisberg

147 views

Managing Advanced Prostate Cancer Pts in Urology Clinics and When to…

UCLA Health

I. Garraway

175 views

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

UCLA Health

Z. Wainberg

287 views

Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

651 views

2024 Updates in Locally Advanced Cervical Cancer

UCLA Health

D. Chase

423 views

Updates in Endometrial Cancer

UCLA Health

R. Salani

352 views

ESMO 2023 Insights: "TROPION-Lung01 Study - Dato-DXd vs. Docetaxel i…

Insights from 2023 ESMO Annual Meeting

A. Lisberg

323 views

2023 ESMO WCGIC Insights: "Additional Results From the Phase 3 NAPOL…

Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting

Z. Wainberg

184 views

ASCO® 2023 Insights: "Phase 3 STELLAR-303 Study - XL092 in Combinati…

Insights from 2023 ASCO® Annual Meeting

J. Hecht

45 views

ASCO® 2023 Insights: "A Phase 1b Trial Evaluating the Safety of Ribo…

Insights from 2023 ASCO® Annual Meeting

N. McAndrew

307 views

Recurrent Cervical Cancer Updates

UCLA Health

R. Salani

478 views

ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposoma…

ASCO GI 2023 Conference Coverage

Z. Wainberg

398 views

ASCO GI 2023 Phase 3 STELLAR-303 Study: XL092 in Combination With At…

ASCO GI 2023 Conference Coverage

J. Hecht

391 views

ASH 2022 Once Weekly Selinexor, Carfilzomib & Dexamethasone (XKd) in…

ASH 2022 Conference Coverage

G. Schiller

52 views

Recurrent Cervical Cancer: Updates on Management

UCLA Health

R. Salani

498 views

Importance of Thoughtful Testing for PIK3CA Mutations in HR+ MBC

UCLA Health

K. McCann

301 views

Efficacy of Datopotamab Deruxtecan in mNSCLC and Actionable Genomic …

UCLA Health

A. Lisberg

191 views

Impact of Androgen Deprivation Therapy Use and Duration With Definit…

UCLA Health

A. Kishan

335 views